Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06431477
PHASE4

Efficacy and Safety of Telmisartan Compared With Losartan

Sponsor: Chong Kun Dang Pharmaceutical

View on ClinicalTrials.gov

Summary

A study to evaluate the efficacy and safety of telmisartan compared with losartan in patients with diabetic nephropathy and hypertension

Official title: A Multi-center, Randomized, Open-label, Active Comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared With Losartan in Patients With Diabetic Nephropathy and Hypertension

Key Details

Gender

All

Age Range

19 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

98

Start Date

2023-04-19

Completion Date

2025-10-31

Last Updated

2024-05-28

Healthy Volunteers

No

Interventions

DRUG

telmisartan

QD, PO

DRUG

Losartan

QD, PO

Locations (1)

Severance Hospital

Seoul, South Korea